ON THIS PAGE: You will find out more about side effects that can occur long after treatment for this type of tumor has finished. To see other pages, use the menu on the side of your screen.
Although many children with Wilms tumor are treated successfully, they often have an increased risk of developing other diseases or conditions later in life, as chemotherapy and radiation therapy can cause permanent damage to healthy parts of the body. Therefore, it is important that children who have received treatment for Wilms tumor are monitored closely for possible long-term or late effects of the treatment. These may include:
Kidney failure. Because children treated for Wilms tumor usually have only one kidney, they have a slightly higher risk of kidney failure and will need to be monitored for the rest of their lives. They also need to keep well hydrated to help promote good kidney health. There are some medications such as codeine and ibuprofen that should only be taken in small amounts to avoid kidney damage.
Bowel obstruction. Depending on the type of surgery, Wilms tumor patients are at risk at any time during their life for developing a bowel obstruction from scar tissue that causes abdominal pain and vomiting.
Heart problems. Children who have received doxorubicin have a higher risk of developing heart abnormalities that can occur even years after treatment has ended. Children treated with doxorubicin who also had radiation therapy to their lungs have an even higher risk of developing heart problems. An echocardiogram may be used to monitor the effects of doxorubicin on the heart.
Skeletal abnormalities. If radiation therapy was given, depending on the location and dose, scoliosis (curvature of the spine) and underdevelopment of the soft tissue may occur.
Secondary cancer. Wilms tumor survivors have a small risk of developing another type of cancer within 15 years after Wilms tumor was first diagnosed. The most important risk factors are whether treatment included radiation therapy and doxorubicin.
Pregnancy concerns. Women who have had abdominal radiation therapy for Wilms tumor should be considered high risk during pregnancy and monitored closely by their doctor. Chemotherapy alone does not increase the risk of miscarriage; however, women who received radiation therapy aimed at the side of the body between the rib and hip, depending on the dose, are more likely to have early labor, an unusual position of the baby’s head during birth, lower birth weight, and premature delivery (less than 36 weeks) based on National Wilms Tumor Study records. Congenital (present at birth) abnormalities are also more common.
The next section helps explain medical tests and check-ups needed after finishing treatment. Use the menu on the side of your screen to select After Treatment, or you can select another section, to continue reading this guide.